NovoSeven RT (Coagulation factor VIIa [recombinant])
Overview NovoSeven RT is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A or B. Typically, NovoSeven RT… read more